Diagnosis and therapy of Rhodococcus equi infection in the horse;De diagnostiek en therapeutische mogelijkheden van een Rhodococcus equi infectie bij het paard

Tijdschrift voor Diergeneeskunde

Volumn 131, Issue 17, 2006, Pages 602-611

  Boswinkel, M ^a   Sloet Van Oldruitenborgh Oosterbaan, M M ^a  

^a Faculty of Veterinary Medicine   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EQUUS CABALLUS; RHODOCOCCUS EQUI;

ANTIINFECTIVE AGENT; AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; RIFAMPICIN;

ANIMAL; ANIMAL DISEASE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; DRUG COMBINATION; ECONOMICS; HORSE; HORSE DISEASE; NEWBORN; REVIEW; RHODOCOCCUS EQUI; TREATMENT OUTCOME;

ACTINOMYCETALES INFECTIONS; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; HORSE DISEASES; HORSES; PNEUMONIA, BACTERIAL; RHODOCOCCUS EQUI; RIFAMPIN; TREATMENT OUTCOME;

EID: 33750124505     PISSN: 00407453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Ainsworth DM, Eicker SW, Yeager AE, Sweeney CR, Viel L, Tesarowski D, Lavoie JP, Hoffman A, Paradis MR, Reed SM, Erb HN, Davidow E, and Nalevanko M. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992). J Am Vet Med Assoc. 1998; 213: 510-515.
2. Anderson G, Esmonde TS, Coles S, Macklin J, and Carnegie C. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. J Antimicrob Chemother. 1991;27:117-124.
3. Arora SK, and Arjunan P. Molecular structure ad conformation of rifamycins, a potent inhibitor of DNA-dependent RNA polymerase. J Antibiot. 1992; 45: 428-431.
4. Barton MD and Hughes KL. Ecology of Rhodococcus equi. Vet Microbiol. 1984; 9: 65-76.
5. Barr BS. Pneumonia in weanlings. Vet Clin North Am Equine Pract. 2003; 19: 35-49.
6. Baverud V, Franklin A, Gunnarsson A, Gustfsson A, and Hellander-Edman A. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicine for Rhodococcus equi pneumonia. Equine Vet J. 1998; 30 (6): 482-488.
7. Baverud V, Gustafsson A, Franklin A, Lindholm A, and Gunnarsson A. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics. Equine Vet J. 1997; 29 (4): 279-284.
8. Baldwin DR, Wise R, Andrews JM, Ashby JP, and Honeybourne D. Azithromycin concentrations at the sites of pulmonary infection. Eur Respir J. 1990; 3: 886-890.
9. Beech J, and Sweeney CR. Infections caused by bacteria, mycoplasma, parasites and fungi. In: Beech J, ed. Equine Respiratory Disorders. Philadelphia: Lea and Febiger, 1991; 181-207.
10. Beier R, Amtsberg G, and Peters M. Bakterriologische Untersuchungen zum Vorkommen und zur Bedeutung von Clostridium difficile beim Pferd. Pferdeheilkunde. 1994; 10: 3-8.
11. Boswinkel M, van der Lugt JJ and Sloet van Oldruitenborgh-Oosterbaan MM. Vertebrale osteomyelitis veroorzaakt door een Rhodococcus equi infectie in een drieënhalf maand oud KWPN veulen. Tijdschr. Diergeneeskunde 2006; 131: 612-616.
12. Brommer H, Sloet van Oldruitenborgh-Oosterbaan MM, and Kessels B. Haematological and blood biochemical characteristics of Dutch Warmblood foals managed under three different rearing conditions from birth to 5 months of age. Vet Quart. 2001; 23 : 92-95.
13. Brumbaugh GW, Davis LE, Thurman JC and Savage DC. Influence of Rhodococcus equi on the respiratory burst of resident alveolar macrophages from adult horses. Am J Vet Res 1990; 51: 766-771.
14. Burrows GE, MacAllister CG, Ewing P, Stair E, and Tripp PW. Rifampin disposition in the horse: effects of age and method of oral administration. J Vet Pharmacol Therap. 1992; 15: 124-132.
15. Castro LA, Brown MP, Gronwall R, Houston AE, and Miles N. Pharmacokinetics of rifampin given as a single oral dose in foals. Am J Vet Res. 1986; 47: 2584-2586.
16. Chaffin MK, and Martens RJ. Extrapulmonary disorders associated with Rhodococcus equi pneumonia in foals: retrospective study of 61 cases (1988-1996). Proc Am Assoc Equine Pract. 1997; 43: 79-80.
17. Chaffin M K, Honnas C M, Crabill M R, Schneiter H L, Brumbaugh G W and Briner R P. Cauda equina syndrome, diskospondylitis, and a paravertebral abscess caused by Rhodococcus equi in a foal. J Am Vet Med Ass. 1995; 206: 215-220.
18. Cosmetatos L, Perrin J, Gallusser A, Nicolet J, and Straub R. Faecal isolation of Clostridium difficile and its toxins from horses with typhlocolitis. In: Proceedings 7th International Conference on Equine Infectious Diseases. 1994. Tokyo, Japan. Poster session 69.
19. Darien BJ, Walker RD, Williams MA, and Derksen FJ. A tracheoscopic technique for obtaining uncontaminated lower airway secretions for bacterial culture in the horse. Equine Vet J. 1990; 22: 170-173.
20. Davis JL, Gardner SY, Yones SL, Schwabenton BA, and Papich MG. Pharmacokinetics of azithromycine in foals after I.V. and oral dose and disposition into phagocytes. J Vet Pharmacol Therap. 2002; 25 (2): 99-104.
21. Debey MC and Bailie WE. Rhodococcus equi in fecal and environmental samples from Kansas horse farms. Vet Microbiol. 1987; 14: 251-257.
22. Desjardins MR and Vachon AM. Surgical management of Rhodococcus equi metaphysitis in a foal. J Am Vet Med Ass. 1990; 197: 608-612.
23. Dowling PM. Antimicrobial therapy. In: Bertone JJ and Horspool LJI. eds. Equine Clinical Pharmacology. 1st ed. London: Saunders, 2004; 43.
24. Elissade GS, Renshaw HW, and Walberg JA. Corynebacterium equi: An interhost review with emphasis on the foal. Comp Immunol Microbiol Infect Dis. 1980; 3: 433-445.
25. Ellenberger MA and Genetzky RM. Rhodococcus equi infections: literature review. Compend Contin Educ Pract Vet 1986; 8: S414-S423.
26. Ensink JM, Bosch G, and van Duijkeren E. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies. J Vet Pharmacol Ther. 2005; 28: 45-49.
27. Ensink JM, Smit JA, and van Duijkeren E. Clinical efficacy of trimethoprim/sulfadiazine and procaine penicillin G in a Streptococcus equi subsp. zooepidemicus infection model in ponies. J Vet Pharmacol Ther. 2003; 26: 247-252.
28. Ewing PJ, Burrows G, MacAllister C, and Clarke C. Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles. J. Vet Pharmac Therap. 1994; 17: 17-23.
29. Falcon J, Smith BP, O'Brien TR, Carlson GP, and Biberstein E. Clinical and radiological findings in Corynebacterium equi pneumonia in foals. J Am Vet Med Ass. 1985; 186: 593-599.
30. Foulds G, Shepard RM, and Johnson RB. The pharmacokinetics of azithromycine in human serum and tissues. J Antimicrob Chemother. 1990; 25(suppl A): 73-82.
31. Giguère S. Rhodococcus equi pneumonia. Proc Am Assoc Equine Pract. 2001; 47: 456-67.
32. Giguère S, Hernandez J, Gaskin J, Miller C, and Bowman JL. Evaluation of white blood cell concentration, plasma fibrinogen concentration, and an agar gel immunodiffusion test for early identification of foals with Rhodococcus equi pneumonia. J Am Vet Med Assoc. 2003; 6: 775-781.
33. Giguère S, Jacks S, Roberts GD, Hernandez J, Long MT, and Ellis C. Retrospective comparison of azithromycine, clarithromycine, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med. 2004; 18: 568-573.
34. Giguère S and Lavoie J P. Rhodococcus equi vertebral osteomyelitis in 3 quarter horse colts. Equine Vet J. 1994; 26: 74-77.
35. Giguère S, and Prescott JF. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococeus equi infections in foals. Vet Microbiol. 1997; 56: 313-334.
36. Giguère S and Prescott J F. Strategies for the control of Rhodococeus equi infections on enzootic frams. Proc Am Assoc Equine Pract. 1997; 43: 65-70 *.
37. Girard AE, Girard D, English AR, Gootz TD, Cimochowski CR, Faiella JA, Haskell SL, and Retsema JA. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother. 1987; 31: 1948-1954.
38. Grosset J. The efficacy of short course chemotherapy for tuberculosis. Bull Pan Am Health Org. 1980; 14: 139-149.
39. Gustafsson A, Baverud V, Gunnarsson A, Horn af Rantzien M, Lindholm A, and Franklin A. The association of erythromycin ethylsuccinate with acute colitis in horses in Sweden. Equine Vet J 1997; 29 (4): 314-318.
40. Hietala SK and Ardens AA. Interaction of Rhodococeus equi with phagocytic cells from R. equi exposed and non-exposed foals. Vet Microbiol. 1987; 14: 307-320.
41. Hillidge CJ. Review of Corynebacterium (Rhodococeus) equi lung abscesses in foals: pathogenesis, diagnosis and treatment. Vet Rec. 1986; 119:261-264.
42. Hillidge CJ. Use of erythromycine-rifampin combination in treatment of Rhodococeus equi pneumonia. Vet Microbiol. 1987; 14: 33-42.
43. Hines MT, Paasch KM, Alperin DC, Palmer GH, Westhoff NC and Hines SA. Immunity to Rhodococeus equi: antigen-specific recall responses in the lungs of adult horses. Vet Immunol Immunopathol. 2001; 79: 101-114.
44. Hondalus MK. Rhodococeus equi: Pathogenesis and Virulence. Proc Am Assoc Equine Pract. 1997; 43: 71-78.
45. Hondalus MK, and Moser DM. Survival and replication of Rhodococeus equi in macrofages. Infect Immun. 1994; 62: 4167-4175.
46. Hopkins S. Clinical toleration and safety of azithromycin. Am J Med. 1991; 91: 40S-45S.
47. Hughes KL and Sulaiman I. The ecology of Rhodococeus equi and physicochemical influences on growth. Vet Microbiol. 1987; 14: 241-250.
48. Jacks S, Giguère S, Gronwall RR, Brown MP, and Merrit KA. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. Am J Vet Res. 2001; 62: 1870-1875.
49. Jacks S, Giguère S, Gronwall RR, Brown MP, and Merritt KA. Disposition of oral clarithromycin in foals. J Vet Pharmacol Ther. 2002; 25: 359-362.
50. Jacks JJ, Giguère S, and Nguyen A. In vitro susceptibilities of Rhodococeus equi and other common equine pathogens to azithromycin. clarithromycin, and 20 other antimicrobials. Antimicrob Agents Chemother. 2003; 47: 1742-1745.
51. Johnson JA, Prescott JF and Markham RJ. The pathology of experimental Corynebacterium equi infection in foals following intrabronchial challenge. Vet Pathol. 1983; 20: 440-449.
52. Jones SL, and Spier SJ. Inflammatory diseases of the large intestine causing diarrhea. In: Reed SM and Bayly WM, eds. Equine Internal Medicine. Philadelphia: WB Saunders, 1998; 663-682.
53. Kennedy DG, Robbins SC, Prescott JF, Kaushik A, and Baird JD. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococeus equi pneumonia. Equine Vet J 1994; 26: 246-248.
54. Lakritz J, and Wilson WD. Erythromycin and other macrolide antibiotics for treating Rhodococeus equi pneumonia in foals. Compend Contin Educ Pract Vet. 2002; 24: 256-261.
55. Lakritz J, Wilson WD, Berry CR, Schrenzel MD, Carlson GP, and Madigan JE. Bronchointerstitial pneumonia and respiratory distress in young horses: clinical, clinical pathologic, radiographic, and pathological findings in 23 cases (1984-1989). J Vet Intern Med. 1993; 7: 277-288.
56. Lakritz J, Wilson WD, and Mihalyi JE. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics and bioavailability of erythromycin base I plasma of foals after intravenous or intragastric administration. Am J Vet Res. 1999; 60: 414-419.
57. Lakritz J. Wilson WD, Marsh AE, and Mihalyi JE. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals. Am J Vet Res. 2000; 61: 1011-1015. (a)
58. Lakritz J, Wilson WD, Marsh AE, and Mihalyi JE. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am J Vet Res. 2000; 61: 914-919. (b)
59. Lavoie JP, Fiset L, and Lverty S. Review of 40 cases of lung abscesses in foals and adult horses. Equine Vet J. 1994; 26: 348-352.
60. Lester GD, Merritt AM, Neuwirth L, Vetro-Widenhouse T, Steible C, and Rice B. Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radio-labeled markers in clinically normal ponies. Am J Vet Res. 1998; 59: 328-334.
61. MacKay RJ and Mayhew IG. Diseases of the nervous system. In: Colahan PT, Mayhew IG, Merrit AM et al., eds. Equine medicine and surgery. 4th ed. Vol 1. Goleta, Calif: American Veterinary Publication, Inc, 1991; 723-845.
62. Madewell BR, Tang YJ, Jang S, Madigan JE Hirsh DC, Gumerlock PH, and Silva J. Apparent outbreak of Clostridium difficile-associated diarrhea in horses in a veterinary medical teaching hospital. J Vet Diagn Invest. 1995; 7: 343-346.
63. Madison JB, and Scarratt WK. Immune-mediated polysynovitis in four foals. J Am Vet Med Assoc. 1988; 192: 1581-1584.
64. Maurin M, and Raoult D. Antibiotic penetration within phagocytic cells. In: Raoult D, ed. Antimicrobial Agents and Intracellular Pathogens. Boca Raton, Fl: CRC Press. 1993: 23-37.
65. Muller NS, and Madigan JE. Methods of implementation of an immunoprophylaxis program for the prevention of Rhodococcus equi pneumonia: results of a 5-year field study. Proc Am Assoc Equine Pract. 1992; 38: 193-201.
66. Murray MJ. Acute culitis. In: Robinson NE. ed. Current Therapy in Equine Medicine 3, 1st edn. Philadelphia: WB Saunders, 1992: 244-250.
67. Nordmann P, and Ronco E. In-vitro antimicrobial susceptibility of Rhodococcus equi. J Antimicrob Chemother. 1992; 29: 383-393.
68. Olchowy TWJ. Vertebral boby osteomyelitis due to Rhodococcus cqui in two arabian foals. Equine Vet J. 1994; 26: 79-82.
69. Otterson MF, and Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol. 1990; 259: G355-G363.
70. Peeters T, Matthijs G, Depoortere I, Hoogmartens J, and Vantrappen G. Erythromycin is a motilin receptor agonist. Am J Physiol. 1989; 257: G470-G474.
71. Perdrizet JA and Scott DW. Cellulitis and subcutaneous abscesses caused by Rhodococcus equi infection in a foal. J Am Vet Med Ass. 1987; 190: 1559-1561.
72. Perrin J, Cosmetatos I, Gallusser A, Lobsiger L, Straub R, and Nicolet J. Clostridium difficile associated with typhlocolitis in an adult horse. J Vet Diagn Invest. 1993; 5: 99-101.
73. Prescott JF. Rhodococcus equi: An animal and human pathogen. Clin Micr Rev. 1991; 4: 20-34.
74. Prescott JF. Lincosamides, macrolides and pleuromutilins. Antimicrobial drugs that inhibit nucleic acid function. In: Prescott JF, Baggot JD. and Walker RD eds. Antimicrobial Therapy in Veterinary Medicine, 3rd edn. Ames: Iowa State University Press. 2000: 237-244.
75. Prescott JF, and Hofmann AM. Rhodococcus equi. In. Traub-Dargatz JL. ed. Vet Clin North Am Equine Pract. Philadelphia: WB Saunders, 1993: 375-384.
76. Prescott JF, Houver DJ, and Dohoo IR. Pharmacokinetics of erythromycin in foals and in adult horses. J Vet Pharmacol Therap. 1983; 6: 67-74.
77. Prescott JF and Muckle CA. Corynebacterium. In: Gyles CL and Thoen CO. eds. Pathogenesis of bacterial Infections in Animals. 1st edn. Ames: Iowa State University Press, 1986: 38-47.
78. Prescott JF, and Nicholson VM. The effects of combination of selected antibiotics on the growth of Corynebacterium equi. J Vet Pharm Ther. 1984; 7: 61-64.
79. Prescott JF, Travers M and Yager-Johnson JA. Epidemiological survey of Corynebacterium equi infections on five Ontario horse farms. Can J Comp Med. 1984; 48: 10-13. *
80. Prescott JF, and Sweeney CR. Treatment of Corynebactrium equi pneumonia of foals: A review. J Am Vet Med Ass. 1985; 187: 725-728.
81. Prokesch RC, and Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antiimicrob Agents Chemother. 1982; 21: 373-380.
82. Reef VB. Thoracic ultrasonography: noncardiac Imaging. In: Reef VB ed. Equine Diagnostic Ultrasound. 1st ed. Philadelphia: WB Saunders, 1998: 202-206.
83. Ringger NC, Lester GD, Neuwirth L, Merritt AM, Vetro T, and Harrison J. Effect of bethanechol or erythromycin on gastric emptying in horses. Am J Vet Res. 1996; 57: 1771-1775.
84. Roberts MC. Acute equine colitis: experimental and clinical perspectives. Vet Ann. 1990; 30: 1-11.
85. Rooney JR. Corynebacterial infections in foals. Mod Vet. Pract. 1966; 47: 43-45.
86. Shepard RM, and Falkner FC. Pharmacokinetics of azithromycine in rats and dogs. J Antimicrob Chemother 1990; 25 (suppl A): 49-60.
87. Sippel WL, Keahey EE and Bullard TL. Corynebacterium infection in foals: Etiology, pathogenesis and laboratory diagnosis. J Am Vet Med Assoc. 1969; 153: 1610.
88. Stratton-Phelps M, Wilson WD, and Gardnes IA. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J Am Vet Med Assoc. 2000; 1: 68-73.
89. Sweeney CR, Sweeney RW, and Divers TJ. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet Microbiol. 1987; 14: 329-336.
90. Takai S, Fujimori T, Katsuzaki K and Tsubaki S. Ecology of Rhodococcus equi in horses and their environment on horse-breeding farms. Vet Microbiol. 1987; 14: 233-239.
91. Takai S, Narita K, Ando K and Tsubaki S. Ecology of Rhodococcus (Corynebacterium) equi in soil on a horse-breeding farm. Vet Microbiol. 1986; 12: 169-177. (a)
92. Takai S, Ohkura H, Watanabe Y and Tsubaki S. Quantitative aspects of fecal Rhodococcus (Corynebacterium) equi in foals. J Clin Microbiol 1986; 23: 794. (b)
93. Takai S, Takahagi J, Sato Y, Yamaguchi K, Kakizaki S, Takehara S, Matsukura S, Tamada Y, Tani A, Sasaki Y, Tsubaki S and Kamada M. Molecular epidemiology of virtulent Rhodococcus equi in horses and their environments. In: Nakajima H and Rossdale PD eds. Equine Infectious Diseases VII. Newmarket: R and W Publications Limited, 1994; 183-187.
94. Thornsberg C, Hill BC, Swenson JM, and McDougal. Rifampin: Spectrum of antibacterial activity review of infectious diseases. 1983; 5: 5412-5417.
95. Traub-Dargatz J, Wilson WD, Conboy HS. Hyperthermia in foals treated with erythromycin alone or in combination with rifampin for respiratory disease during hot environmental conditions. In: Proceedings of the Am Assoc Equine Pract 1996; 42:243-244.
96. Valdes A, and Johnson JR. Septic pleuritis and abdominal abscess formation caused by Rhodococcus equi in a foal. J Am Vet Med Assoc. 2005; 227: 960-963, 919.
97. Whitlock RH. Colitis: differential diagnosis and treatment. Equine Vet J. 1986; 18: 278-283.
98. Whitman MS, and Tunkel AR. Azithromycin and clarithromycine: overview and comparison with erythromycin. Infect Control Hosp Epidemiol. 1992; 13: 357-368.
99. Wilson MM. A study of Corynebacterium equi infection in a study of thoroughbred horses in Victoria. Aust. Vet J. 1955; 31: 175.
100. Wilson WD. Foal pneumonia: An overview. Proc Am Assoc Equine Pract. 1992; 38: 203-229 (a)
101. Wilson WD. Foal pneumonia. In: Robinson NE ed. Current Therapy in Equine Medicine, 3rd Ed. Philadelphia: WB Saunders, 1992: pp. 466-473 (b)
102. Woolcock JB and Mutiner MD. Corynebacterium equi in the gastrointestinal tract of ruminants. Vet Res Commun. 1981; 4: 291-294.
103. Woolcock JB, Mutimer MD and Farmer AM. Epidemiology of Corynebacterium equi in horses. Res Vet Sci. 1980; 28: 87-90.
104. Zertuche JML, and Hillidge CJ. Therapeutic considerations for Rhodococcus equi pneumonia in foals. Vet Clin North Am Equine Pract. 1987; 9: 965-971.
105. Zink MC, Yager JA, Prescott JF and Fernando MA. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol. 1987; 14: 295-305.
106. Zink MC, Yager JA, Prescott JF and Wilkie BN. In vitro phagocytosis and killing of Corynebacterium equi by alveolar macrophages of foals. Am J Vet Res. 1985; 46: 2171-2174.
107. Zink MC, Yager JA, and Smart NL. Corynebacterium equi infections in horses 1958-1984: a review of 131 cases. Can Vet J 1986; 27: 213-217.